Analyst Ratings for Myriad Genetics Inc. (MYGN)

Updated: 2017-07-26

An average rating of Hold has been given to Myriad Genetics Inc. (NASDAQ:MYGN) by analysts covering the stock. MYGN had previously received a consensus rating of Hold a month ago.

15 analysts issued ratings on the stock, where 2 gave MYGN a buy rating, 0 issued an overweight rating, 9 gave a hold rating, 1 gave an underweight rating, and 3 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for MYGN. The most optimistic price target was 30, implying potential capital gains of 26.37 percent. The most pessimistic price target was 16, implying potential capital losses of -32.6 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -1.65 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.56 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 2 analysts revised their FY earnings estimates upwards, compared to 0 analysts that revised their FY estimates downwards.

Analysts estimate earnings of MYGN to grow at a rate of 135.64 percent. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, though it could be better to see where the ratio stands relative to peers in the industry. MYGN has a PEG ratio of 0.39.

In the last 52-weeks, MYGN has achieved a high of 32.54 and a low of 15.15. Currently the stock is 56.7 percent higher than its low, and 27.04 percent lower than its 52-week high. MYGN has a price/earnings ratio of 52.76. Investors typically compare the P/E ratio to a company's peers in the industry. The MYGN value stock report compares MYGN to some of its peers using value stock charts. The stock has a market capitalization of $1.63 billion. MYGN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.